pediatric neurology
Professional fieldWikipedia
7
MENTIONS
6
EPISODES
4
PODCASTS
Search complete. 7 mentions across 6 episodes found for "pediatric neurology".
Oct 4, 2026
Sam MackenzieHOST
Hopefully we do.
Sam MackenzieHOST
I just wanted to start by launching right in and maybe you can give us kind of a high level overview for people who aren't aware of what's happening in graduate medical education as it pertains to child neurology training.
Sam MackenzieHOST
Why should we care? Why do we need to know what's going on? How can we help kind of improve things, make it better?
Don GilbertGUEST
Well, I think the question of why should we care about Child neurology education is really the question of why should we care about children that have neurological problems? I think that's really where we should start.
Helen FarmerHOST
Really appreciate it.
Helen FarmerHOST
And listen, if anyone wants to get in touch and send me the brain emoji, I will send you details of our expert this hour, uh, Dr. Arif Khan, and he can be found in person, um, at NeuroPediatrics.
Helen FarmerHOST
Um, you've, you've made me feel better and somewhat worse [laughs] Dr. Arif.
Arif KhanGUEST
Oh.
Helen FarmerHOST
They're gonna have an increasing role in our children's lives, but they are very, very powerful indeed.
Helen FarmerHOST
So thank you for your guidance.
Helen FarmerHOST
And of course, Dr. Arif Khan, consultant pediatric neurologist, the founder of NeuroPediatrics.
Helen FarmerHOST
[upbeat music] Welcome to your Money Matters.
speaker_0NARRATOR
The October 2026 issue of Developmental Medicine and Child Neurology is out now.
speaker_0NARRATOR
The following papers are included in this issue.
speaker_0NARRATOR
A narrative review examines recent advances in migraine in children and adolescents, highlighting its complex polygenic etiology, current understanding of pathophysiology, and emerging mechanism-based therapies.
Russell DaleGUEST
Hello, my name is Russell Dale from the University of Sydney.
Russell DaleGUEST
It's great to have this opportunity to talk about a paper that we're proud of and grateful for Developmental Medicine and Child Neurology for publishing our work.
Russell DaleGUEST
The title of our study is Shared Disregulation of Complement and Phosphorylation Pathways in the cerebrospinal fluid of encephalitis saccardiogutier syndrome and autism.
Russell DaleGUEST
I'm also delighted to say that this is a collaborative piece of work in the Westmead precinct in Western Sydney between the Children's Hospital, the Children's Medical Research Institute and the University of Sydney.
Emma GlissonGUEST
I am a speech and language therapist working with children with acquired brain injuries in an acute neuro rehabilitation service.
Emma GlissonGUEST
I'm going to talk to you about our recent paper published in Developmental Medicine and Child Neurology earlier this year, which looks at dysphagia or difficulty swallowing following pediatric acquired brain injury.
Emma GlissonGUEST
So firstly, just a little bit of background around swallowing.
Emma GlissonGUEST
Swallowing is a complex neurological process which involves multiple regions of the brain, cranial nerves and motor neurons, and these systems work together to support the coordination of around 30 pairs of muscles, which support three phases of the swallow.
Kleopas KleopaMODERATOR
And today we are happy to have as guest Professor Joe Eng, who is Senior Research Fellow at the University College London, Queen's Square Institute of Neurology.
Kleopas KleopaMODERATOR
Professor Eng has started her career with an MRC Clinical Research Training Fellowship after completing Pediatric Neurology Training at Great Ormond Street Hospital for Children and Then she went on to complete a PhD in gene therapy at UCL and combining her clinical experience of managing children with incurable life-threatening and life-limiting neurogenetic disorders without any impactful treatments, And combining with her research experience, she decided to combine this in her career and develop a gene therapy for these rare neurogenetic disorders in order to improve the therapeutic landscape for patients with neurological diseases.
Kleopas KleopaMODERATOR
So she has developed considerable expertise in translational AAV gene therapy, and has been able to bring some of these treatments all the way to clinical testing and first in human trials.
Kleopas KleopaMODERATOR
So we're very excited to hear her voice and I will start.